Dovitinib Triggers Apoptosis and Autophagic Cell Death by Targeting SHP-1/p-STAT3 Signaling in Human Breast Cancers

Breast cancer is the most common cancer and the leading cause of cancer deaths in women worldwide. The rising incidence rate and female mortality make it a significant public health concern in recent years. Dovitinib is a novel multitarget receptor tyrosine kinase inhibitor, which has been enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Yi-Han, Lee, Yi-Yen, Huang, Kuo-Chin, Liu, Cheng-Chi, Lin, Chen-Si
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710795/
https://www.ncbi.nlm.nih.gov/pubmed/31485222
http://dx.doi.org/10.1155/2019/2024648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710795/
https://www.ncbi.nlm.nih.gov/pubmed/31485222
http://dx.doi.org/10.1155/2019/2024648

Ejemplares similares